{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:03:13Z","timestamp":1792015393438,"version":"4.4.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>There are limited data on the risk of new-onset anxiety disorders in patients with hidradenitis suppurativa (HS).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To compare the risk of new-onset anxiety disorder in patients with HS and controls, and to describe risk factors for the development of anxiety in patients with HS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We carried out a retrospective cohort analysis of a US electronic health records database between 2011 and 2020. Adults newly diagnosed with HS at a dermatology or primary care visit and control participants were included. The primary outcome was a new diagnosis of generalized anxiety disorder, phobic disorders, panic disorder or unspecified anxiety. Cox proportional hazards regression was used to compare the crude risk of any anxiety disorder between groups and to assess the independent association with HS while controlling for potential demographic, clinical and healthcare-related confounders.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 9597 patients with HS and 959 493 controls, the incidence rate (IR) of anxiety was 5.74 and 3.86 per 100 person-years (PY), respectively. The crude risk among all patients was 48% higher for those with HS vs. controls [hazard ratio (HR) 1.48, 95% confidence interval (CI) 1.40\u20131.55]. When stratified by index encounter type, patients with HS had 2.43 (95% CI 2.13\u20132.77) times the risk of anxiety disorder than dermatology controls and 1.46 (95%CI 1.38\u20131.55) times the risk than primary care controls. The adjusted HR for patients with HS vs. controls was 1.11 (95% CI 1.05\u20131.17) overall, 1.26 (95% CI 1.07\u20131.48) in the dermatology subgroup and 1.07 (95% CI 1.01\u20131.13) in the primary care subgroup. Risk factors for an incident anxiety diagnosis among patients with HS included depression (HR 1.69, 95% CI 1.48\u20131.93), female sex (HR 1.41, 95% CI 1.23\u20131.60), younger age (HR 0.87 per 10-year increase, 95% CI 0.84\u20130.90), White race, in the Medicaid insurance programme (HR 1.22, 95% CI 1.07\u20131.40), tobacco smoking (HR 1.16, 95% CI 1.03\u20131.31) and having one or more emergency department visits in the year before a HS diagnosis. Absolute IRs of anxiety disorders were highest among patients with HS who were aged 18\u201329\u2005years (7.10 per 100 PY), female (6.34 per 100 PY) and White (6.79 per 100 PY).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>HS is independently associated with an increased risk of anxiety disorders. An increased risk remains but is attenuated when confounders are controlled for. The relative risk may be particularly high in patients managed by dermatologists.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjd\/ljae139","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T23:01:54Z","timestamp":1712098914000},"page":"351-356","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of anxiety disorder in adults with hidradenitis suppurativa"],"prefix":"10.1093","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7965-5090","authenticated-orcid":false,"given":"Erica","family":"Cohn","sequence":"first","affiliation":[{"name":"Northwell, New Hyde Park, NY , USA"},{"name":"Department of Dermatology, Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Palma","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY , USA"},{"name":"Department of Dermatology, Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Mastacouris","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY , USA"},{"name":"Department of Dermatology, Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY , USA"},{"name":"Department of Dermatology, Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-6856","authenticated-orcid":false,"given":"Amit","family":"Garg","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY , USA"},{"name":"Department of Dermatology, Zucker School of Medicine at Hofstra\/Northwell , New Hyde Park, NY , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"2024081418363964800_ljae139-B1","author":"Real-world evidence solutions for life sciences"},{"key":"2024081418363964800_ljae139-B2","author":"SNOMED CT"},{"key":"2024081418363964800_ljae139-B3","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"Loinc, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"key":"2024081418363964800_ljae139-B4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for clinical drugs: Rxnorm at 6\u2005years","volume":"18","author":"Nelson","year":"2011","journal-title":"J Am Med Inform Assoc"},{"key":"2024081418363964800_ljae139-B5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000468148","article-title":"Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database","volume":"233","author":"Strunk","year":"2017","journal-title":"Dermatology"},{"key":"2024081418363964800_ljae139-B6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jclinepi.2016.07.004","article-title":"Appropriate inclusion of interactions was needed to avoid bias in multiple imputation","volume":"80","author":"Tilling","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2024081418363964800_ljae139-B7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"2024081418363964800_ljae139-B8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000490002","article-title":"Inflammation: a contributor to depressive comorbidity in inflammatory skin disease","volume":"31","author":"Farzanfar","year":"2018","journal-title":"Skin Pharmacol Physiol"},{"key":"2024081418363964800_ljae139-B9","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (voice) project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024081418363964800_ljae139-B10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1159\/000453355","article-title":"Quality of life and psychosocial implications in patients with hidradenitis suppurativa","volume":"232","author":"Kouris","year":"2016","journal-title":"Dermatology"},{"key":"2024081418363964800_ljae139-B11","doi-asserted-by":"crossref","first-page":"729104","DOI":"10.3389\/fpsyt.2021.729104","article-title":"Sexuality in persons with hidradenitis suppurativa: factors associated with sexual desire and functioning impairment","volume":"12","author":"Quinto","year":"2021","journal-title":"Front Psychiatry"},{"key":"2024081418363964800_ljae139-B12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","article-title":"Hidradenitis suppurativa markedly decreases quality of life and professional activity","volume":"62","author":"Matusiak","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"2024081418363964800_ljae139-B13","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/jamadermatol.2018.2117","article-title":"Association of low socioeconomic status with hidradenitis suppurativa in the United States","volume":"154","author":"Wertenteil","year":"2018","journal-title":"JAMA Dermatol"},{"key":"2024081418363964800_ljae139-B14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjd.14266","article-title":"Self-reported pain management in hidradenitis suppurativa","volume":"174","author":"Ring","year":"2016","journal-title":"Br J Dermatol"},{"key":"2024081418363964800_ljae139-B15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0304-3959(03)00301-4","article-title":"Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample","volume":"106","author":"McWilliams","year":"2003","journal-title":"Pain"},{"key":"2024081418363964800_ljae139-B16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2024081418363964800_ljae139-B17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5114\/ada.2022.119080","article-title":"Depression and anxiety in hidradenitis suppurativa patients: a cross-sectional study among Polish patients","volume":"40","author":"Rymaszewska","year":"2023","journal-title":"Adv Dermatol Allergol"},{"key":"2024081418363964800_ljae139-B18","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","article-title":"The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis","volume":"8","author":"Kimball","year":"2018","journal-title":"Dermatol Ther"},{"key":"2024081418363964800_ljae139-B19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/jdv.12567","article-title":"Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa","volume":"29","author":"Shavit","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024081418363964800_ljae139-B20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaad.2019.11.068","article-title":"Association between hidradenitis suppurativa, depression, anxiety, and suicidality: a systematic review and meta-analysis","volume":"83","author":"Patel","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024081418363964800_ljae139-B21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000444082","article-title":"Patients with rosacea have increased risk of depression and anxiety disorders: a Danish nationwide cohort study","volume":"232","author":"Egeberg","year":"2016","journal-title":"Dermatology"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljae139\/57671157\/ljae139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/3\/351\/58820351\/ljae139.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/191\/3\/351\/58820351\/ljae139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T18:36:54Z","timestamp":1723660614000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/191\/3\/351\/7639140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":21,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,2]]},"published-print":{"date-parts":[[2024,8,14]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljae139","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,9]]},"published":{"date-parts":[[2024,4,2]]}}}